CPRX logo

Catalyst Pharmaceuticals, Inc. (CPRX) return on equity

annual ROE:

29.38%+8.63%(+41.59%)
December 31, 2024

Summary

  • As of today (September 10, 2025), CPRX annual return on equity is 29.38%, with the most recent change of +8.63% (+41.59%) on December 31, 2024.
  • During the last 3 years, CPRX annual ROE has risen by +8.40% (+40.04%).
  • CPRX annual ROE is now -49.61% below its all-time high of 58.30%, reached on December 31, 2020.

Performance

CPRX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXprofitability metrics

quarterly ROE:

28.60%-0.83%(-2.82%)
June 30, 2025

Summary

  • As of today (September 10, 2025), CPRX quarterly return on equity is 28.60%, with the most recent change of -0.83% (-2.82%) on June 30, 2025.
  • Over the past year, CPRX quarterly ROE has increased by +13.67% (+91.56%).
  • CPRX quarterly ROE is now -57.34% below its all-time high of 67.04%, reached on September 30, 2020.

Performance

CPRX quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

CPRX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+41.6%+91.6%
3 y3 years+40.0%+10.8%
5 y5 years-36.2%-39.8%

CPRX ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-10.3%+41.6%-24.7%+91.6%
5 y5-year-49.6%+41.6%-57.3%+91.6%
alltimeall time-49.6%+104.6%-57.3%+102.0%

CPRX ROE History

DateAnnualQuarterly
Jun 2025
-
28.60%(-2.8%)
Mar 2025
-
29.43%(+5.8%)
Dec 2024
29.38%(+41.6%)
27.81%(0.0%)
Sep 2024
-
27.81%(+86.3%)
Jun 2024
-
14.93%(-8.0%)
Mar 2024
-
16.22%(-20.7%)
Dec 2023
20.75%(-36.7%)
20.45%(+7.3%)
Sep 2023
-
19.05%(-49.9%)
Jun 2023
-
38.00%(+4.4%)
Mar 2023
-
36.40%(+8.5%)
Dec 2022
32.76%(+56.1%)
33.54%(+14.0%)
Sep 2022
-
29.43%(+14.0%)
Jun 2022
-
25.81%(+13.8%)
Mar 2022
-
22.68%(+8.3%)
Dec 2021
20.98%(-64.0%)
20.94%(-10.2%)
Sep 2021
-
23.31%(-49.7%)
Jun 2021
-
46.35%(-8.1%)
Mar 2021
-
50.45%(-15.9%)
Dec 2020
58.30%(+26.6%)
60.01%(-10.5%)
Sep 2020
-
67.04%(+41.2%)
Jun 2020
-
47.49%(-16.0%)
Mar 2020
-
56.55%(+17.4%)
Dec 2019
46.06%(-189.2%)
48.17%(+213.4%)
Sep 2019
-
15.37%(-176.8%)
Jun 2019
-
-20.01%(-56.7%)
Mar 2019
-
-46.19%(-6.8%)
Dec 2018
-51.62%(+68.6%)
-49.55%(+29.0%)
Sep 2018
-
-38.40%(+6.3%)
Jun 2018
-
-36.11%(-2.7%)
Mar 2018
-
-37.10%(-10.9%)
Dec 2017
-30.62%(-19.7%)
-41.64%(-11.3%)
Sep 2017
-
-46.96%(+9.4%)
Jun 2017
-
-42.93%(+4.2%)
Mar 2017
-
-41.21%(+7.0%)
Dec 2016
-38.13%(-14.5%)
-38.53%(-0.0%)
Sep 2016
-
-38.54%(+5.1%)
Jun 2016
-
-36.66%(+7.4%)
Mar 2016
-
-34.13%(-5.3%)
Dec 2015
-44.61%(-18.6%)
-36.03%(+5.4%)
Sep 2015
-
-34.18%(-10.2%)
Jun 2015
-
-38.08%(-12.2%)
Mar 2015
-
-43.35%(-15.0%)
DateAnnualQuarterly
Dec 2014
-54.77%(-18.9%)
-50.99%(+6.0%)
Sep 2014
-
-48.12%(-24.4%)
Jun 2014
-
-63.63%(-24.9%)
Mar 2014
-
-84.74%(+12.8%)
Dec 2013
-67.50%(+52.2%)
-75.13%(-4.8%)
Sep 2013
-
-78.93%(+10.7%)
Jun 2013
-
-71.31%(+38.8%)
Mar 2013
-
-51.36%(-7.0%)
Dec 2012
-44.35%(-67.8%)
-55.23%(-54.5%)
Sep 2012
-
-121.41%(+8.5%)
Jun 2012
-
-111.85%(-19.0%)
Mar 2012
-
-138.10%(+5.4%)
Dec 2011
-137.76%(+125.8%)
-131.01%(+46.3%)
Sep 2011
-
-89.52%(+11.0%)
Jun 2011
-
-80.66%(+7.6%)
Mar 2011
-
-74.97%(+16.8%)
Dec 2010
-61.00%(-23.4%)
-64.20%(-11.9%)
Sep 2010
-
-72.90%(-8.0%)
Jun 2010
-
-79.26%(-1.4%)
Mar 2010
-
-80.41%(-18.8%)
Dec 2009
-79.68%(+1.4%)
-98.97%(-13.3%)
Sep 2009
-
-114.14%(+2.2%)
Jun 2009
-
-111.66%(+11.7%)
Mar 2009
-
-100.00%(+30.1%)
Dec 2008
-78.60%(+243.4%)
-76.88%(+49.3%)
Sep 2008
-
-51.51%(+44.4%)
Jun 2008
-
-35.66%(+35.9%)
Mar 2008
-
-26.24%(+14.1%)
Dec 2007
-22.89%(-14.9%)
-22.99%(-10.6%)
Sep 2007
-
-25.71%(-32.6%)
Jun 2007
-
-38.14%(+7.7%)
Mar 2007
-
-35.40%(-3.0%)
Dec 2006
-26.90%(-95.8%)
-36.50%(-88.3%)
Sep 2006
-
-311.96%(-73.9%)
Jun 2006
-
-1193.21%(+108.3%)
Mar 2006
-
-572.86%(-11.3%)
Dec 2005
-640.10%(+184.7%)
-646.18%(-55.3%)
Sep 2005
-
-1444.30%(+6.7%)
Jun 2005
-
-1353.40%(+49.3%)
Mar 2005
-
-906.29%(+97.4%)
Dec 2004
-224.82%(+6.9%)
-459.18%
Dec 2003
-210.36%(-63.1%)
-
Dec 2002
-569.93%
-

FAQ

  • What is Catalyst Pharmaceuticals, Inc. annual return on equity?
  • What is the all time high annual ROE for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. annual ROE year-on-year change?
  • What is Catalyst Pharmaceuticals, Inc. quarterly return on equity?
  • What is the all time high quarterly ROE for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. quarterly ROE year-on-year change?

What is Catalyst Pharmaceuticals, Inc. annual return on equity?

The current annual ROE of CPRX is 29.38%

What is the all time high annual ROE for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high annual return on equity is 58.30%

What is Catalyst Pharmaceuticals, Inc. annual ROE year-on-year change?

Over the past year, CPRX annual return on equity has changed by +8.63% (+41.59%)

What is Catalyst Pharmaceuticals, Inc. quarterly return on equity?

The current quarterly ROE of CPRX is 28.60%

What is the all time high quarterly ROE for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high quarterly return on equity is 67.04%

What is Catalyst Pharmaceuticals, Inc. quarterly ROE year-on-year change?

Over the past year, CPRX quarterly return on equity has changed by +13.67% (+91.56%)
On this page